Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
216080
vs
K
KOSPI 200
Over the past 12 months, Jetema Co Ltd has underperformed KOSPI 200, delivering a return of +1% compared to KOSPI 200's +50% growth.
Stocks Performance
216080 vs KOSPI 200
Performance Gap
216080 vs KOSPI 200
Performance By Year
216080 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jetema Co Ltd
Glance View
Jetema Co Ltd is a South Korean medical aesthetics company that develops and sells products used in cosmetic procedures. Its core offerings include injectable fillers, botulinum toxin products, and other device-based treatments that doctors use to smooth wrinkles, restore facial volume, and improve appearance without major surgery. The company works mainly with dermatology clinics, plastic surgery practices, and other medical providers that buy these products for in-office treatments. Jetema makes money by selling these medical products to healthcare providers and distributors, both in Korea and in overseas markets where aesthetic medicine demand is strong. In this business, the company sits between drug and device makers on one side and clinics on the other: it formulates, manufactures, and commercializes products that practitioners apply directly to patients. That makes its business model different from a typical consumer brand, because sales depend on medical adoption, practitioner trust, and regulatory approval rather than retail shelf space. For investors, the key thing to understand is that Jetema is tied to the global beauty and minimally invasive treatment market. Its value comes from product quality, safety, and repeat use by clinics that want reliable results for patients. The company’s role is to supply the tools that doctors use in aesthetic procedures, which gives it exposure to a specialized healthcare niche rather than broad consumer goods.